A passion for outthinking cancer
Eric, Associate Director at Merrimack
Our collaborations

Innovation doesn’t happen alone.
Learn more about teaming with Merrimack.

Learn more

News

View all news
November 07, 2018

Merrimack Reports Third Quarter 2018 Financial Results and Provides Strategic Update Following Portfolio Review

Read more
October 31, 2018

Merrimack Announces Timing of Third Quarter 2018 Investor Conference Call

Read more
October 19, 2018

Merrimack Discontinues Phase 2 SHERLOC Study of MM-121 in Patients with Non-Small Cell Lung Cancer Due to Futility

Read more
September 20, 2018

Merrimack Receives $5 Million Milestone Payment from Shire

Read more

Social Media

Follow us on Twitter

October 8, 2018
@MerrimackPharma
We are taking a systematic approach to our preclinical development work. Learn more about our pipeline here: http://wwZRfyJQ2f

October 5, 2018
@MerrimackPharma
Our pipeline is shaped by understanding cancer pathways, treatments designed with pharmacological properties to mat… http://XYlHtTVLHu